The Greek parliament announced on Tuesday the results of a judicial investigation into alleged bribes paid to public officials by Basel-based NovartisExternal link over nearly a decade to boost subscriptions of their products at public hospitals.
“This is a massive scandal that has stunned Greek society,” government spokesman Dimitris Tzanakopoulos said.
Under Greek law, politicians do not face prosecution directly from judicial authorities. Allegations must first be referred to parliament for review before lawmakers vote to strip the accused of their automatic immunity.
The politicians named include current Bank of Greece governor Yannis Stournaras and EU Home Affairs Commissioner Dimitris Avramopoulos, plus former conservative prime minister Antonis Samaras, the caretaker prime minister Panagiotos Pikramenos in 2012 and five former health ministers. They have all denied the allegations.
Samaras, the former conservative prime minister who served between 2012 and 2015, said the allegations against him were politically motivated, and vowed to file a lawsuit against left-wing Prime Minister Alexis Tsipras.
“This is the most ruthless but also most ridiculous conspiracy ever,” he said.
Novartis said it is cooperating with Greek authorities.
Popular Stories
More
Multinational companies
Azeri fossil-fuel cash cow brings controversy to Switzerland
Swiss price watchdog slams excessive prices for generic medicines
This content was published on
The cheapest generic medicines available in Switzerland are more than twice as expensive as in other countries, according to a study by the Swiss price watchdog.
Nature should not figure in net zero calculations: academic study
This content was published on
The natural removal of CO2 from the atmosphere by forests or oceans should not be included in the net-zero balance of climate protection measures, argue researchers.
This content was published on
None of the 15 major Swiss retail banks is meeting international climate and biodiversity targets, according to a ranking by WWF Switzerland.
This content was published on
Nestlé's new CEO Laurent Freixe, has presented plans for the future of the world's largest food company, after his first few weeks in office.
Swiss foreign minister calls on Moscow to end Ukraine war
This content was published on
It's high time Moscow ended its war against Ukraine, Swiss foreign minister Ignazio Cassis tells the UN Security Council.
This content was published on
The only alternative to the UN Palestinian agency’s work in Gaza is to allow Israel to run services there, Philippe Lazzarini, UNRWA Commissioner-General, told reporters in Geneva on Monday.
Study reveals food culture differences between Switzerland and neighbours
This content was published on
Three-quarters of Swiss people consider eating to be a pleasurable, social activity, a new survey reveals. Healthy eating, however, plays a much less important role, it found.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
New Novartis chief eyes productivity revolution
This content was published on
Vas Narasimhan estimates that using digital technology more efficiently could save up to 25% on the cost of clinical trials.
Will exclusive collaborations yield more drug breakthroughs?
This content was published on
Recently FDA-approved, Novartis's pioneering immunotherapy was developed through an agreement with University of Pennsylvania researchers.
Pharma turns to big data to gauge care and pricing
This content was published on
Struggling to keep pace with digitisation, big pharma companies are turning to big data to drive future growth. Swiss-based Novartis is no different.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.